Matchpoint Therapeutics has entered into an exclusive option and license agreement with Novartis to develop and commercialize oral covalent inhibitors.

Researchers have engineered ultra-thin ion-selective membranes with sub-2-nanometre channels, enabling more efficient clean ...

To develop a covalent modifier for the amyloid-forming protein β-2-microglobulin (magenta), researchers used a nanobody (teal ...

Monitoring and understanding the photocatalytic reactions at individual covalent organic framework (COF) photocatalysts are crucial for gaining insights into their structure–activity relationships.

The potential of solar energy as a sustainable power source remains hindered by various efficiency limitations. One of the major challenges is the accumulation of dust on photovoltaic (PV) panels, ...

In situ polymerization in a covalent organic framework boosts lithium-ion conduction in solid polymer electrolytes, advancing energy storage technology.

Block copolymers (BCPs) containing polymerized ionic liquids (PILs) have garnered considerable interest in ion-conducting applications due to their tunable physicochemical properties and intrinsic ion ...